The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
FOLFOXIRI with or without bevacizumab as first-line treatment for unresectable liver-only metastatic colorectal cancer patients with RAS mutation-type.
 
Yanhong Deng
No Relationships to Disclose
 
Huabin Hu
No Relationships to Disclose
 
Guanjian Liu
No Relationships to Disclose
 
Yue Cai
No Relationships to Disclose
 
Jianwei Zhang
No Relationships to Disclose
 
Meijin Huang
No Relationships to Disclose
 
Lei Wang
No Relationships to Disclose
 
Lan Ping
No Relationships to Disclose
 
Jianping Wang
No Relationships to Disclose